According to Dicerna Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $0.19 B. In 2020 the company made a revenue of $0.16 B an increase over the years 2019 revenue that were of $23.9 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2021 (TTM) | $0.19 B | 17.37% |
2020 | $0.16 B | 587.36% |
2019 | $23.9 M | 287.05% |
2018 | $6.17 M | 171.23% |
2017 | $2.27 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Pfizer PFE | $58.49 B | 30,232.90% | ๐บ๐ธ USA |
Amgen AMGN | $28.19 B | 14,517.58% | ๐บ๐ธ USA |
Merck MRK | $60.11 B | 31,071.38% | ๐บ๐ธ USA |
Regulus Therapeutics RGLS | N/A | N/A | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $1.82 B | 848.04% | ๐บ๐ธ USA |
Arrowhead Pharmaceuticals
ARWR | $0.18 B | -5.76% | ๐บ๐ธ USA |